Treatment Approach to Coronavirus Disease (COVID-19) Seen Early After Open Heart Surgery. Case Report

Çelik, Ersin; Çora, Ahmet Rıfkı

doi:10.1007/s42399-020-00377-y

Cited by 5 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some studies 32,[49][50][51] reported successful surgery in positive patients, but it also has been shown that COVID-19 pneumonia may frequently complicate the postoperative course, also in those who become positive after surgery. 32 Accordingly there is the need to add perioperative SARS-CoV-2 infection into common perioperative risk scores, such as the Society of Thoracic Surgeon score and EuroSCORE.…”

Section: Cardiac Surgery Procedures and Coronavirus Disease-2019mentioning

confidence: 99%

See 1 more Smart Citation

The day after tomorrow: cardiac surgery and coronavirus disease-2019

Bonalumi

Giambuzzi

Buratto³

et al. 2021

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

The impact of the coronavirus disease-2019 (COVID-19) pandemic forced the governments worldwide to deal with an unprecedented health crisis. The aim of this review is to summarize what happened to cardiac surgery worldwide during the first wave of this pandemic. A literature search was performed to extrapolate key concepts regarding guidelines and reorganization of cardiac surgery wards during COVID-19. Supporting literature was also included to discuss the hot topics related to COVID-19 and cardiac surgery. Hence, both official documents from national scientific societies and single-or multiple-center experiences during the pandemics are reviewed and discussed. In Italy, the first western country hit by the pandemic, two different models were proposed to cope with the need for ICU/ward beds and to reallocate cardiac surgical services: Hub-and-Spoke system ('Hubs', dedicated to perform urgent and nondeferrable surgery, and 'Spokes', turned into COVID centers) and/or a progressive reduction in surgical activity. Worldwide, several guidelines/consensus statements were published, suggesting how to deal with the outbreak. Two different approaches for stratifying surgical indications were proposed: dynamic, based on the number of hospitalized COVID-19 patients; static, based only on the severity of the cardiovascular disease. Moreover, the importance of personal protective equipment was stressed. Several measures should have been adopted to deal with an unprecedented need for healthcare resources allocation to care for COVID-19 patients, putting the healthcare systems under serious stress. Cardiac surgery has, as have most surgical activities, been asked to reduce its own activity, giving priority to emergency and nondeferrable cases.

show abstract

Section: Cardiac Surgery Procedures and Coronavirus Disease-2019mentioning

confidence: 99%

“…Some studies 32,49–51 reported successful surgery in positive patients, but it also has been shown that COVID-19 pneumonia may frequently complicate the postoperative course, also in those who become positive after surgery 32 …”

Section: Introductionmentioning

confidence: 99%

The day after tomorrow: cardiac surgery and coronavirus disease-2019

Bonalumi

Giambuzzi

Buratto³

et al. 2021

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

show abstract

“…The patient became afebrile the third day after treatment, and the vital signs were stable by the fifth day of surgery. 18 …”

Section: Discussionmentioning

confidence: 99%

Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient

Fakharian

Barati

Mohamadi³

et al. 2022

Journal of Cardiothoracic and Vascular Anesthesia

View full text Add to dashboard Cite

“…Despite the fact that some patients are asymptomatic, SARS-CoV-2 infectious disease led to around 20% of patients being admitted to the intensive care unit (ICU), and 70% of inpatients being intubated (Luo et al, 2020;Petrilli et al, 2020). However, in clinical studies and the experience of many physicians, very contradictory results emerged regarding patients who were admitted to the intensive care unit, were intubated, and given antiviral treatments (C ¸elik and C ¸ora, 2020;Elavarasi et al, 2020;Ghazy et al, 2020;Kılıc ¸et al, 2021;Ladapo et al, 2020;Meng et al, 2020;Nadaroglu, 2020;Zhou et al, 2020). Countries followed various or similar treatment algorithms; still, the risk factors impacting the clinical states of patients have yet to be completely understood.…”

Section: Introductionmentioning

confidence: 99%

The effect of antiviral treatment on SARS-CoV-2 infectious disease progression: A comparison of the multi-state models

Potas

2021

KJS publishes peer-review articles in Mathematics, Computer Sci

View full text Add to dashboard Cite

Combating SARS-CoV-2 is the first concern and goal of the whole world faced with the global health crisis. Since 2019, the SARS-CoV-2 infection (COVID-19) and even mutated infection cases have been increasing rapidly. From 2019 through 27 August 2021, a total of 214,468,601 individuals were confirmed cases of SARS-CoV-2, including 4,470,969 death toll. Some of these individuals were able to access treatment and some could not, but for a while there was complete uncertainty. It was not known whether those who accessed treatment were lucky, but treatment was based on trial and error because of this uncertainty around the world until data was collected. Therefore, the aim of this study was to model SARS-CoV-2 infectious disease progression from the date of polymerase chain reaction (PCR) test to the date of negative outcome via Bayesian multi-state model approaches considering risk factors such as gender, age, and antiviral treatment. Data from 746 inpatients were collected from August 1st until the December 1st, 2020. For the multi-state model, five various discrete states were selected according to the Republic of Turkey Ministery of Health treatment algorithm. The results showed that Bayesian multi-state models with the Weibull distributed baseline hazard function were more appropriate models in the presence of risk factors and antiviral treatment.

show abstract

Treatment Approach to Coronavirus Disease (COVID-19) Seen Early After Open Heart Surgery. Case Report

Cited by 5 publications

References 6 publications

The day after tomorrow: cardiac surgery and coronavirus disease-2019

The day after tomorrow: cardiac surgery and coronavirus disease-2019

Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient

The effect of antiviral treatment on SARS-CoV-2 infectious disease progression: A comparison of the multi-state models

Contact Info

Product

Resources

About